The growing prominence of the life sciences industry has sparked a wave of real estate development globally, with Beijing and Shanghai leading global life sciences construction activity with more than 13.7 million square feet combined, according to a new report from CBRE.
CBRE analyzed many of the key life sciences markets across the globe and found that overall, most demand drivers are improving. Global venture capital investment in life sciences companies last year exceeded the 2019 total by 43 percent. In-progress construction of lab space globally totaled more than 35 million square feet last year.
“Beijing, Shanghai, Singapore, and Greater Tokyo are the largest life sciences markets in the Asia Pacific region,” said Paul Peeters, senior director, APAC head of life sciences, advisory and transaction services, for CBRE. “While China leads the world in in-progress lab construction, India is emerging as an attractive life sciences manufacturing hub. We witness s
